Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II).
James W JakubMichael LoweJ Harrison HowardJeffrey M FarmaAmod SarnaikTodd TuttleHeather B NeumanCharlotte E AriyanAbhineet UppalSteve TrochaGeorgia M BeasleyNabil WasifKarl Y BilimoriaAlan A ThomayJacob B AllredLucia ChenAlicia M TerandoJeffrey D WayneJohn F ThompsonAlistair J CochranMyung-Shin SimDavid E ElashoffKeith A DelmanMark B FariesPublished in: Annals of surgical oncology (2022)
This large multi-institutional experience supports the oncologic safety of MILND for melanoma. The outcomes in this large multi-institutional experience of MILND compared favorably with those for an OILND population during similar periods, supporting the oncologic safety of MILND for melanoma.